The first stop for professional medicines advice

Co-careldopa

Published
Topics: Co-careldopaMental health and illnessNeurological disorders · Safety in BreastfeedingStability in dosette boxes ·
Contents
  1. dm+d
  2. Articles
  3. Medicine Compliance Aid Stability
    1. generic · Teva UK Ltd
    2. Caramet CR · Teva UK Ltd
    3. Sinemet · Organon Pharma (UK) Limited
    4. Half Sinemet CR & Sinemet CR · Organon Pharma (UK) Limited
  4. Lactation Safety Information
    1. Carbidopa + levodopa

dm+d

404830004

Articles

Parkinson’s disease medicines in swallowing difficulties

13 June 2022Guidance to help you ensure your patients with Parkinson’s Disease are able to get the most from their medicines if they develop swallowing difficulties
Search Articles

Medicine Compliance Aid Stability

genericTeva UK Ltd

Teva UK Ltd
generic
Tablets 10/100, 25/100, 25/250mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
Protect from light
Protect from moisture
Protect from light. Protect from moisture.
30 June 2022
Usage of Medicines in Compliance Aids

Caramet CRTeva UK Ltd

Teva UK Ltd
Caramet CR
Tablets m/r 25/100, 50/200
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Protect from light. Protect from moisture.
30 June 2022
Usage of Medicines in Compliance Aids

SinemetOrganon Pharma (UK) Limited

Organon Pharma (UK) Limited
Sinemet
Tablets 62.5 (12.5mg/50mg), 110 (10mg/100mg), Plus (25/100mg), 275mg (25/250)
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Complex dosing regime. Protect from moisture. Max 7 days in MCA
9 November 2022
Usage of Medicines in Compliance Aids

Half Sinemet CR & Sinemet CROrganon Pharma (UK) Limited

Organon Pharma (UK) Limited
Half Sinemet CR & Sinemet CR
Tablets m/r 25/100mg, 50/200mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from moisture
Complex dosing regime. Protect from moisture. Max 7 days in MCA
9 November 2022
Usage of Medicines in Compliance Aids

Lactation Safety Information

Carbidopa + levodopa

Carbidopa + levodopa
Caution
Low levels anticipated in milk due to the drug's properties
Limited published evidence of safety of levodopa and no published evidence for carbidopa
May interfere with lactation although less likely if lactation established. Monitor milk production
Safety in Lactation: Dopaminergic drugs used in Parkinsons disease
30 July 2020
LactMed